# Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease

> **NCT01055392** · PHASE2 · UNKNOWN · sponsor: **University of Sao Paulo** · enrollment: 80 (estimated)

## Conditions studied

- Cognitive Impairment
- Alzheimer Disease

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01055392
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055392, "Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01055392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*